文献速递乳腺病理

乳腺癌分级不一致对预后预测的影响

Impact of breast cancer grade discordance on prediction of outcome.
PubMed 文献 · Histopathology · 2018-09-19

本研究在1675例乳腺癌队列中,由专家病理医师用虚拟显微镜间隔3个月两次重新分级,评估分级不一致对预后价值的影响。不一致病例生存介于相邻级别之间,但更接近较高级别。建议对交界性病例重复分级或双报告以改善与预后的相关性。

要点

  • 乳腺癌分级不一致病例的预后更接近较高级别。
  • 1/2级不一致病例预后差于1级(P=0.008),与2级无差异。
  • 2/3级不一致病例预后差于2级(P<0.001),与3级无差异。

核心结论

  • 乳腺癌分级不一致可能反映生物学和形态学上的交界性肿瘤。
  • 交界性病例的行为更接近较高级别 category。
  • 重复分级或双报告可能改善分级与预后的相关性。

研究设计与样本

  • 大型 annotated 乳腺癌队列(n=1675),最初常规实践用玻璃切片分级。
  • 由一位专家乳腺病理医师使用虚拟显微镜间隔3个月洗脱期重新分级两次。
  • 结局评估采用乳腺癌特异生存和无远处转移生存,中位随访135个月。

主要发现

  • 虚拟显微镜下观察者内绝对一致率为77%,1/2级和2/3级不一致分别占13%和10%。
  • 三个分级 sessions 中肿瘤分级与患者结局均显示显著关联。
  • 1/2级不一致病例生存介于1级和2级之间,差于1级(P=0.008),与2级无统计学差异。
  • 2/3级不一致病例生存介于2级和3级之间,差于2级(P<0.001),与3级无统计学差异。

临床怎么用

  • 对分级交界性病例可考虑重复组织学分级或双报告。
  • 交界性病例的预后判断应倾向于较高级别 category。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Histological grade is an independent prognostic variable in breast cancer (BC). Previous concordance studies of BC grade have reported moderate levels of agreement; a typical finding in morphological assessment of biological variables. This study aimed to investigate the impact of discordance on the prognostic value of grade and to identify the best reporting approach in borderline cases. METHODS AND RESULTS: A large (n = 1675) well-characterised annotated cohort of BC, originally graded in routine practice using glass slides, was re-graded twice by an expert breast pathologist using virtual microscopy with a 3-month washout period. Outcome was assessed using breast cancer-specific and distant metastasis-free survival (median follow-up = 135 months). Fifty-eight per cent of the cases showed absolute agreement in the three separate grading sessions, whereas grades 1/2 and 2/3 discordance were observed in 21% and 21%, respectively. Absolute intra-observer agreement using virtual microscopy was observed in 77% of the cases, whereas 13% and 10% showed grades 1/2 and 2/3 discordance, respectively. Despite the concordance, outcome analysis revealed significant associations between tumour grade and patients' outcome in the three grading sessions. Grades 1/2 and 2/3 discordant cases showed intermediate survival between grades 1 and 2 tumours and grades 2 and 3 tumours, respectively. Grades 1/2 discordant cases showed a worse outcome when compared with grade 1 tumours (P = 0.008) but no statistical difference was identified when compared with grade 2 tumours. Similarly, grades 2/3 discordant cases showed a significant difference from grade 2 tumours (P < 0.001), but no statistical difference was identified when compared with grade 3 tumours. CONCLUSIONS: Breast cancer grade discordance is probably a reflection of biologically, and hence morphologically, borderline tumours. Cases with borderline features for grade are more likely to behave similarly to the higher-grade category. Repeating histological grade of borderline cases or double reporting may improve correlation with outcome.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Rakha EA, Aleskandarany MA, Toss MS, et al. Impact of breast cancer grade discordance on prediction of outcome. Histopathology. 2018. PMID: 29999192. doi:10.1111/his.13709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。